马来西亚采购需求：骨髓瘤疾病、多发性骨髓瘤病、骨髓瘤多发性癌症、膀胱癌、皮肤癌、Cart T 细胞

I am reaching out with a medical inquiry regarding NK cell therapy for a 59-year-old female patient from Malaysia. She has a history of left breast cancer diagnosed on 31/5/2018 as ductal carcinoma in-situ, nuclear grade 3. Recently, on 3/2/2025, there was a diagnosis of left breast cancer with axillary lymph node metastasis. The patient has completed chemotherapy as of 17/6/2025 and radiotherapy on 1/8/2025. She is currently undergoing hormone therapy with Letrozole 2.5mg daily. We are interested in exploring the potential benefits of NK cell therapy and would like to arrange a consultation for further information.